Beta Bionics, Inc.

IPO

iLet Bionic Pancreas – the insulin pump that automatically learns and adapts to you.

Boston, United States · Founded 2018 · $275.6M raised

Employees
11–50
Founded
2018
Business Model
B2C
Total Funding
$275.6M
Last Round
$60.0M Series ENov 2024
Rounds
5

About

Beta Bionics is a Boston-based medical device company dedicated to making diabetes management easier. The company developed the iLet Bionic Pancreas, an FDA-cleared automated insulin delivery system for people with type 1 diabetes aged 6 and older. The iLet uses continuous glucose monitor data to autonomously calculate and deliver all insulin doses without carb counting.

Summary

Beta Bionics, Inc. is a Digital Health company based in Boston, United States, founded in 2018. It has raised $275.6M in total across 5 rounds, most recently a $60.0M Series E round in Nov 2024. Investors include Wellington Management, Sands Capital and Eventide Asset Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJan 2025
$234.6M

Sign up to see all 6 rounds

Equity Crowdfunding through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Beta Bionics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/beta-bionics-inc"><img src="https://indexed.vc/api/badge/company/beta-bionics-inc" alt="Beta Bionics, Inc. on Indexed.vc" width="260" height="76" /></a>